How investors view Emerging Markets (EM) investing can vary widely, even within State Street Global Advisors. Laura Ostrander from our Fundamental Growth and Core Equity (FGC) team and Chris Laine from our Active Quantitative Equity (AQE) team to discuss four key topics that are relevant to EM investors
If you have been lucky enough to be stranded in a safe – but unconnected – place for the last six or seven months, you’ll be forgiven for thinking that 2020 has been a pretty boring year for the markets. Your investments in emerging market (EM) stocks are likely flat. Did anything interesting really happen? If only.
A range of major policy changes is creating winners and losers among Chinese drug companies, as well as promising new ancillary business models.
Policy-makers in China changed policy direction by implementing new security measures in Hong Kong and removing a target for GDP growth. These economic cum political decisions should continue to make Chinese assets attractive for global investors, though they could pose a relative headwind for other Emerging Markets. Yet, market dynamics will depend more on how DM countries manage their exits from lockdown.
Success in EM investing requires recognizing how companies and countries are evolving during the COVID-19 pandemic. We assess market liquidity, corporates’ flexibility to change and valuations to identify opportunities.
State Street Global Advisors investment experts share their perspectives on emerging markets (EM) investing in the context of current market volatility and the COVID-19 crisis.
After several tumultuous months, emerging market equities are rebounding. In this piece, members of our fundamental active equities team share seven key points about emerging markets (EM) that are shaping their EM equities portfolio right now.